Evidence map›Paper›PMID 33771408›Full record

ReviewLa Revue de medecine interne2021

[COVID-19 and medical publications: How three articles have influenced the media and public decisions in France].

F Péretz, J Bonini-Vuillod, M Grivaux, M Duracinsky, O Chassany

Erratum issuedAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in La Revue de medecine interne, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

F PéretzAbelia Science, 1, allée des Sablons, 89000 Saint-Georges-sur-Baulche, France. Electronic address: fperetz@abelia-science.fr.
J Bonini-VuillodAbelia Science, 1, allée des Sablons, 89000 Saint-Georges-sur-Baulche, France.
M GrivauxCentre de recherche clinique, hôpital de Meaux, 77100 Meaux, France.
M DuracinskyDépartement de médecine interne et d'immunologie clinique, hôpital Bicêtre, Assistance Publique-hôpitaux de Paris (AP-HP), Paris, France; Unité de recherche clinique en economie de la santé, URC-ECO, hôpital Hôtel-Dieu, AP-HP, Paris, France; Patient-centered outcomes research, UMR 1123, université Paris-Inserm, Paris, France.
O ChassanyUnité de recherche clinique en economie de la santé, URC-ECO, hôpital Hôtel-Dieu, AP-HP, Paris, France; Patient-centered outcomes research, UMR 1123, université Paris-Inserm, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present article details the publication process and the vicissitudes of three articles about SARS-CoV-2 and its related disease (COVID-19). The three articles were published one month apart between March and May 2020. Their mediatization led French health authorities to intervene. Our article does not focus on and does not assess the scientific quality of the articles presented, but only aims to open the reflection on medical publication. Beyond the description of these three specific cases, this article raises issues about article retraction, peer-reviewing, preprints, authorship and the dissemination of scientific medical information, including through the mass media. It discusses new publishing modes and the dissemination of published information in clinical research.

Indexed as

Communications MediaCOVID-19Information DisseminationPublic OpinionPublishingData AccuracyDecision MakingFranceHumansPublicationsPublic Health AdministrationSARS-CoV-2AuthorshipCOVID-19Évaluation par les pairsJournalPaternitéPeer-reviewPreprintPrépublicationRevue

Identifiers

PMID33771408
PMCPMC7986470

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.